Published in Blood Weekly, April 24th, 2003
For patients who responded at 3 months, 86% were alive after 5 years. Overall survival of patients 7 years following combination therapy was 55%, according to the study, published in the Journal of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.